Annual EBITDA:
$42.97M+$92.38M(+186.97%)Summary
- As of today, VCYT annual EBITDA is $42.97 million, with the most recent change of +$92.38 million (+186.97%) on December 31, 2024.
- During the last 3 years, VCYT annual EBITDA has risen by +$104.78 million (+169.51%).
- VCYT annual EBITDA is now at all-time high.
Performance
VCYT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$19.80M+$13.49M(+213.70%)Summary
- As of today, VCYT quarterly EBITDA is $19.80 million, with the most recent change of +$13.49 million (+213.70%) on June 30, 2025.
- Over the past year, VCYT quarterly EBITDA has increased by +$9.36 million (+89.59%).
- VCYT quarterly EBITDA is now at all-time high.
Performance
VCYT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$61.50M+$9.36M(+17.95%)Summary
- As of today, VCYT TTM EBITDA is $61.50 million, with the most recent change of +$9.36 million (+17.95%) on June 30, 2025.
- Over the past year, VCYT TTM EBITDA has increased by +$29.10 million (+89.80%).
- VCYT TTM EBITDA is now at all-time high.
Performance
VCYT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VCYT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +187.0% | +89.6% | +89.8% |
| 3Y3 Years | +169.5% | +720.1% | +513.7% |
| 5Y5 Years | +650.5% | +323.6% | +326.7% |
VCYT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +169.5% | at high | +777.0% | at high | +502.8% |
| 5Y | 5-Year | at high | +169.5% | at high | +344.3% | at high | +326.7% |
| All-Time | All-Time | at high | +169.5% | at high | +298.1% | at high | +280.2% |
VCYT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $19.80M(+213.7%) | $61.50M(+17.9%) |
| Mar 2025 | - | $6.31M(-63.5%) | $52.14M(+10.5%) |
| Dec 2024 | $42.97M(+187.0%) | $17.31M(-4.3%) | $47.19M(+35.6%) |
| Sep 2024 | - | $18.08M(+73.1%) | $34.80M(+7.4%) |
| Jun 2024 | - | $10.44M(+666.3%) | $32.40M(+48.4%) |
| Mar 2024 | - | $1.36M(-72.3%) | $21.84M(+24.4%) |
| Dec 2023 | -$49.41M(-379.7%) | $4.91M(-68.7%) | $17.55M(+1.8%) |
| Sep 2023 | - | $15.68M(>+9900.0%) | $17.25M(+1925.0%) |
| Jun 2023 | - | -$118.00K(+96.0%) | -$945.00K(+76.5%) |
| Mar 2023 | - | -$2.92M(-163.5%) | -$4.02M(+56.3%) |
| Dec 2022 | -$10.30M(+83.3%) | $4.61M(+283.7%) | -$9.20M(+39.7%) |
| Sep 2022 | - | -$2.51M(+21.5%) | -$15.27M(-2.7%) |
| Jun 2022 | - | -$3.19M(+60.6%) | -$14.87M(-6.0%) |
| Mar 2022 | - | -$8.11M(-454.0%) | -$14.02M(-149.4%) |
| Dec 2021 | -$61.81M(-131.2%) | -$1.46M(+30.5%) | -$5.62M(+27.8%) |
| Sep 2021 | - | -$2.11M(+10.3%) | -$7.78M(-10.6%) |
| Jun 2021 | - | -$2.35M(-901.0%) | -$7.04M(+48.1%) |
| Mar 2021 | - | $293.00K(+108.1%) | -$13.55M(+43.2%) |
| Dec 2020 | -$26.74M(-242.5%) | -$3.62M(-166.4%) | -$23.84M(+12.1%) |
| Sep 2020 | - | -$1.36M(+84.6%) | -$27.13M(-2.1%) |
| Jun 2020 | - | -$8.86M(+11.4%) | -$26.57M(-33.6%) |
| Mar 2020 | - | -$10.00M(-44.5%) | -$19.89M(-80.6%) |
| Dec 2019 | -$7.80M(+54.4%) | -$6.92M(-767.8%) | -$11.01M(-78.1%) |
| Sep 2019 | - | -$797.00K(+63.4%) | -$6.18M(+29.0%) |
| Jun 2019 | - | -$2.18M(-93.9%) | -$8.71M(+24.0%) |
| Mar 2019 | - | -$1.12M(+46.2%) | -$11.46M(+37.4%) |
| Dec 2018 | -$17.12M | -$2.09M(+37.2%) | -$18.31M(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$3.32M(+32.6%) | -$21.27M(+8.8%) |
| Jun 2018 | - | -$4.93M(+38.2%) | -$23.32M(+3.1%) |
| Mar 2018 | - | -$7.97M(-58.2%) | -$24.06M(-6.0%) |
| Dec 2017 | -$23.76M(+5.5%) | -$5.04M(+6.2%) | -$22.70M(-11.2%) |
| Sep 2017 | - | -$5.38M(+5.1%) | -$20.42M(-7.3%) |
| Jun 2017 | - | -$5.67M(+14.4%) | -$19.03M(+17.0%) |
| Mar 2017 | - | -$6.62M(-139.4%) | -$22.92M(+9.4%) |
| Dec 2016 | -$25.14M(+19.1%) | -$2.76M(+30.7%) | -$25.29M(+15.3%) |
| Sep 2016 | - | -$3.99M(+58.3%) | -$29.87M(+12.5%) |
| Jun 2016 | - | -$9.55M(-6.3%) | -$34.12M(-3.4%) |
| Mar 2016 | - | -$8.99M(-22.5%) | -$33.00M(-5.7%) |
| Dec 2015 | -$31.07M(-11.9%) | -$7.34M(+11.0%) | -$31.21M(+1.2%) |
| Sep 2015 | - | -$8.24M(+2.2%) | -$31.59M(-8.7%) |
| Jun 2015 | - | -$8.43M(-17.1%) | -$29.06M(-8.0%) |
| Mar 2015 | - | -$7.20M(+6.7%) | -$26.92M(-3.4%) |
| Dec 2014 | -$27.76M(-14.0%) | -$7.72M(-35.0%) | -$26.03M(-9.4%) |
| Sep 2014 | - | -$5.72M(+9.0%) | -$23.79M(+0.4%) |
| Jun 2014 | - | -$6.28M(+0.4%) | -$23.89M(-4.8%) |
| Mar 2014 | - | -$6.31M(-15.2%) | -$22.79M(-2.8%) |
| Dec 2013 | -$24.35M(-35.7%) | -$5.48M(+5.7%) | -$22.17M(-2.5%) |
| Sep 2013 | - | -$5.81M(-12.1%) | -$21.63M(-5.1%) |
| Jun 2013 | - | -$5.19M(+9.0%) | -$20.58M(-3.7%) |
| Mar 2013 | - | -$5.70M(-15.4%) | -$19.84M(-8.9%) |
| Dec 2012 | -$17.94M(-29.7%) | -$4.94M(-3.7%) | -$18.22M(-37.1%) |
| Sep 2012 | - | -$4.76M(-7.0%) | -$13.29M(-55.9%) |
| Jun 2012 | - | -$4.45M(-9.2%) | -$8.53M(-109.2%) |
| Mar 2012 | - | -$4.08M | -$4.08M |
| Dec 2011 | -$13.83M | - | - |
FAQ
- What is Veracyte, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Veracyte, Inc.?
- What is Veracyte, Inc. annual EBITDA year-on-year change?
- What is Veracyte, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Veracyte, Inc.?
- What is Veracyte, Inc. quarterly EBITDA year-on-year change?
- What is Veracyte, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Veracyte, Inc.?
- What is Veracyte, Inc. TTM EBITDA year-on-year change?
What is Veracyte, Inc. annual EBITDA?
The current annual EBITDA of VCYT is $42.97M
What is the all-time high annual EBITDA for Veracyte, Inc.?
Veracyte, Inc. all-time high annual EBITDA is $42.97M
What is Veracyte, Inc. annual EBITDA year-on-year change?
Over the past year, VCYT annual EBITDA has changed by +$92.38M (+186.97%)
What is Veracyte, Inc. quarterly EBITDA?
The current quarterly EBITDA of VCYT is $19.80M
What is the all-time high quarterly EBITDA for Veracyte, Inc.?
Veracyte, Inc. all-time high quarterly EBITDA is $19.80M
What is Veracyte, Inc. quarterly EBITDA year-on-year change?
Over the past year, VCYT quarterly EBITDA has changed by +$9.36M (+89.59%)
What is Veracyte, Inc. TTM EBITDA?
The current TTM EBITDA of VCYT is $61.50M
What is the all-time high TTM EBITDA for Veracyte, Inc.?
Veracyte, Inc. all-time high TTM EBITDA is $61.50M
What is Veracyte, Inc. TTM EBITDA year-on-year change?
Over the past year, VCYT TTM EBITDA has changed by +$29.10M (+89.80%)